Dr. Samin K. Sharma is an interventional cardiology expert, well known for performing high risk complex coronary interventions with an extremely high success rate (>99%) while achieving an extremely low complication rate (<0.5% major complication). He has received the prestigious ** star designation (significantly lower than expected mortality) numerous times by the NY State Department of Health and the Governor’s Award of Excellence in Medicine in 1996.
He has served on New York State’s Cardiac Advisory Board since 2004. Under Dr. Sharma’s leadership, the Mount Sinai Hospital Cardiac Cath Lab has become one of the safest and busiest centers in New York, providing state-of-the-art cardiac and interventional care for all types of simple and complex heart patients. In addition to coronary interventions, Dr. Sharma specializes in the non-surgical treatment of mitral and aortic valve disease including transcatheter aortic valve replacement (TAVR) and MitraClip procedures (TMVR). He has been dubbed “master of Rotablator” and is regularly featured on national and local TV and in newspapers and magazine including Newsday, Newsweek, New York Times, New York Post, Forbes, Wall Street Journal, New York Daily News, Washington Post, New York Magazine, India Abroad and India Today.
He has received numerous awards: 2015 Honorary Master of Science PhD degree by Rajasthan University Jaipur India, 2014 Distinguished Physician Scientist by AAPI-QLI, 2011 Ellis Island Medal of Honor, 2011 American Heart Association Achievement in Cardiovascular Science & Medicine Award, 2011 Physician of the Year form American Association of Physicians of Indian Origin (AAPI), 2010 Association of Indians in America (AIA) for excellence in Medicine, 2003-2007 and 2010-2015 Best Doctors by New York Magazine, 2008-2015 Super Doctors, 2007 Jacobi Medallion Award by Mount Sinai Hospital, 2007 Physician of the Year by Mount Sinai Hospital. He has authored over 230 papers and 13 book chapters in the field of coronary interventions, structural heart disease and safety of percutaneous interventions. He is also a philanthropist and Mount Sinai Cath Lab is now named as the Dr Samin K Sharma Family Foundation Cardiac Catheterization Laboratory. Dr Sharma has built a 250 bedded (heart) hospital (EHCC) in his native place Jaipur India to provide the best affordable care to all patients irrespective of their financial and social status.
Dr. Annapoorna Kini is a Professor of Medicine and the Director of Cardiac Catheterization Laboratory at The Mount Sinai Hospital. Dr. Kini is an international leader in the field of percutaneous coronary intervention and heart valve therapy.
After receiving her medical degree from India, Dr. Kini completed her residency and cardiology training in England, followed by a fellowship in general cardiology and interventional cardiology at Icahn School of Medicine at Mount Sinai School of Medicine. In 2002, she joined the faculty of Cardiac Catheterization Laboratory and Intervention and is currently the Professor of Cardiology, Director of the Cardiac Catheterization Laboratories, and the Director of Interventional Cardiology Fellowship Program at The Mount Sinai Hospital.
Dr. Kini is internationally acclaimed for her special expertise in performing complex coronary interventions especially in chronic total occlusion for patients with advanced coronary artery disease, high-risk interventional cases, and septal (alcohol) ablation for the treatment of obstructive hypertrophic cardiomyopathy. She has an extensive experience with the techniques of mitral and aortic balloon valvuloplasty, and has been among the first interventional cardiologists in the country to use transcutaneous aortic valve implantation procedure in the treatment of patients with aortic stenosis.
Dr. Kini performs over 1,000 coronary interventions annually, the highest number by a female interventionist in the United States, with an extremely low complication rate of less than 0.3 percent; an official report from The Department of Health recognized Dr. Kini as the safest operator among 350 other physicians in the state of New York numerous times (2004-2006; 2005-2007; 2009-2011; 2010-2013). She is the recipient of 2011 Dean's Award for Excellence in Clinical Medicine at The Mount Sinai Medical Center. She also received the Physician of the year award in 2014 by the Mount Sinai Hospital nurses.
Dr. Sameer Mehta, MD, FACC, MBA, has pioneered a new specialty, that of the STEMI Interventionalist, with his groundbreaking work on short door-to-balloon time STEMI interventions. The Single Individual Community Experience Registry (SINCERE) database, now in its seventh year, is the source of this innovative work that is also taught at LUMEN, the Annual Symposium on Optimal Treatment for Acute MI. Dr. Mehta is assisting numerous countries in his global pursuit to improve population-based STEMI care.